Adela Presents Data Demonstrating Ability of Tissue-Agnostic MRD Assay to Predict Recurrence in Head & Neck Cancer at the American Association for Cancer Research Annual Meeting 2024

/PRNewswire/ -- Adela, Inc., an innovator in blood testing for minimal residual disease monitoring and early cancer detection through a proprietary genome-wide...

Related Keywords

Canada ,United States ,Toronto ,Ontario ,American ,Geoffrey Liu ,Scientist At Princess Margaret Cancer Centre ,University Health Network ,Adela Inc ,Princess Margaret Cancer Centre ,Prnewswire Adela Inc ,American Association For Cancer Research ,American Association ,Cancer Research ,Annual Meeting ,Scott Bratman ,Chief Innovation Officer ,Radiation Oncologist ,University Health ,Board Number ,F Prime Capital ,Deerfield Management ,Decheng Capital ,Margaret Cancer Centre ,Foster City ,Nadela ,